Merge subject to Nasdaq delisting

Merge Technologies (Milwaukee), doing business as Merge Healthcare , reported that because the company has not yet filed its annual report on Form 10-K for the year ended Dec. 31, it received a Nasdaq Staff Notification on March 20 stating that the company is not in compliance with Nasdaq's Marketplace Rule 4310(c)(14), and that its securities are subject to delisting from the Nasdaq National Market.

In accordance with Nasdaq rules, Merge has requested a hearing before a Nasdaq Listing Qualifications panel for continued listing on the Nasdaq Stock Market. No action will be taken to delist Merge's common stock until the panel has completed its review, though there can be no assurance that the panel will grant Merge's request for continued listing.

Medical device summit planned

The Medical Device R&D Summit, planned for Nov. 12-14 on the West Coast, will examine the “extensive challenges“ affecting product development, benchmarking techniques for systems geared toward defining consumer needs, thereby aiding in the development of successful device design.

The summit is expected to promote R&D innovation by presenting a complimentary balance of business, human and scientific viewpoints. Topics to be covered on the program include but are not limited to issues surrounding expediting time to market, increasing quality assurance, CRO issues and integrating disciplined product development processes.

For more information, go to